Form D · Biotechnology
JHBP (CY) Holdings Ltd
Shanghai, F4 · CIK 0001791631
Offering snapshot reported Nov 13, 2019 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $10M Reported outside-investor minimum
- First sale
- Sep 26, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 13, 2019 | Initial | $0 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-353225
A portion of the issuer's shares are offered in an "earn-out" arrangement, and as a result, the offering and sales amounts are difficult to ascertain or calculate at this time.
Source: Form D, filed Nov 13, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yu Chen | Director |
| Yong Chen | Director |
| Zhou Xu | Executive |
| Qingqing Yu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Bldg. 3, 1690 Zhangheng Rd. Pudong New District
Shanghai, F4, 201203
Shanghai, F4, 201203